Correlation between pain response and improvements in patient-reported outcomes and health-related quality of life in duloxetine-treated patients with diabetic peripheral neuropathic pain
Kei Ogawa,1 Shinji Fujikoshi,2 William Montgomery,3 Levent Alev1 1Medical Science, 2Statistical Science, Eli Lilly Japan K.K., Kobe, Japan; 3Global Patient Outcomes and Real World Evidence, Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia Objective: We assessed whether quality of life (QoL)...
Guardado en:
Autores principales: | Ogawa K, Fujikoshi S, Montgomery W, Alev L |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0d6f41d2b34647118208035a1f1841c1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine
por: Lindsay Zilliox, et al.
Publicado: (2010) -
Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine
por: Russell J, et al.
Publicado: (2010) -
An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life
por: Kuga A, et al.
Publicado: (2017) -
Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy
por: Kuga A, et al.
Publicado: (2019) -
Duloxetine in panic disorder with somatic gastric pain
por: Preve M, et al.
Publicado: (2013)